Dr. Michael I Zuflacht M.D.

Recommended Articles

• Neuroprotection: New Possible Treatment for Multiple Sclerosis

  Researchers are continuously uncovering new ways to help cure multiple sclerosis (MS). One area in particular that shows promising results is neuroprotection. Neuroprotection aims to prevent nerve cells from becoming damaged, thus slowing down the progression of the disease. Initially, MS symptoms...

• Can You Overdose on Xanax? How Much Xanax Does it Take to Overdose?

  Before Taking this DrugInform your doctor if you have any of the following conditions before taking Xanax (alprazolam):...

• Lemtrada Gains FDA Approval to Treat Multiple Sclerosis

  In the United States alone, over 400,000 individuals are dealing with the challenges associated with multiple sclerosis (MS). Most recently, Sanofi, an international leader in healthcare, announced FDA approval of the prescription drug Lemtrada, for the treatment of patients with relapsing forms of...

• What Is Normal Pressure Hydrocephalus?

  Normal pressure hydrocephalus (NPH) is a type of brain disorder, wherein excess cerebrospinal fluid builds up in the ventricles of the brain. It causes problems in reasoning, thinking, difficulty in walking, and loss of bladder control.Brains ventricles are hollow fluid-filled chambers. Even...

• Parkinson's Debate: Should Patients Really Be Considered Sick?

  ‘Sick’ is a word that gets tossed around fairly often when referring to people who are suffering from different types of disease, and while this word might be fitting for those that have come down with some sort of passing condition (flu, chicken pox, etc.), it might not be very appropriate when...

• Childhood Alzheimer's Patient Dies due to Accident in Hospice Care

  Mark and Lisa Bushaway, both 48 years old and living in the UK, grieve the loss of their 21-year-old daughter Emily due to Neimann-Pick Type C, otherwise known as childhood Alzheimer's, and are devastated to learn their younger daughter Sarah also has the genetic disorder.“With one, you think you...